26 April 2017
Washington DC
Reporter: Barney Dixon

Patent dance question to be heard today


The US Supreme Court will today (26 April) hear oral arguments in the highly anticipated Amgen v Sandoz litigation on the patent dance procedure.

A decision in favour of Sandoz could lead to a new definition of the patent dance procedures contained in the Biologics Price Competition and Innovation Act (BPCIA).

Amgen asked the Supreme Court whether biosimilar applicants must adhere to the BPCIA’s two-stage process that requires applicants to file an Abbreviated Biologics License Application along with providing the patent owner with information about the applicant’s manufacturing process, otherwise known as the ‘patent dance’.

Applicants then have 180 days to provide the patent owner with notice of Food and Drug Administration (FDA) approval.

Brendan O’Malley, partner at Fitzpatrick, Cella, Harper & Scinto, commented: “Reference product sponsors believe a reversal on this question would lead to chaos, in part because they would have no way to predict when a launch might be imminent, making it difficult to obtain a preliminary injunction before the biosimilars enter the market.”

The Supreme Court also faces a separate question from Sandoz, which asks whether the notice of commercial marketing can be effective in general.

O’Malley said that an affirmation on this question could be a reference sponsor’s sole mechanism for patent enforcement if the biosimilar applicant declines to engage in the patent dance.

“A reversal on this question could help to restore reference product sponsors’ expectation that an early and orderly pathway would exist for enforcing their patent rights.”

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Businesses should prepare for UPC, despite uncertainty
17 October 2017 | London | Reporter: Barney Dixon
Businesses should make preparations for the Unified Patent Court and unitary patent, despite mounting uncertainty surrounding when, if at all, the court will come into effect
Patent ‘irrationality’ causes a negative image of patents
16 October 2017 | London | Reporter: Barney Dixon
Spectators are far more accepting of copyright and trademarks than they are of patents because of “irrationality”, according to Sir Robin Jacob
Partner promotions at White & Case
13 October 2017 | New York | Reporter: Barney Dixon
White & Case has promoted 31 new partners, including four intellectual property attorneys, across the US and UK
Qualcomm hit with $775 million fine in Taiwan
13 October 2017 | Taipei | Reporter: Barney Dixon
Qualcomm has been hit with a $775 million fine, after the Taiwan Fair Trade Commission found that the chipmaker had abused its position in the baseband chip market
SUEPO willing to work with new EPO president
12 October 2017 | Munich | Reporter: Barney Dixon
A source close to the Staff Union of the European Patent Office has revealed it is always willing to work with whoever is elected to lead the European Patent Office
BPTO and EPO sign PPH cooperation treaty
12 October 2017 | São Paulo | Reporter: Barney Dixon
The Brazilian Patent and Trademark Office and the European Patent Office have signed a cooperation treaty, aimed at the creation of a patent prosecution highway between the two offices
Johnson Controls-Hitachi selects Anaqua
11 October 2017 | Boston | Reporter: Barney Dixon
The joint venture between Johnson Controls and Hitachi Air Conditioning has chosen intellectual property analytics company Anaqua to globalise its IP management systems